Vera Therapeutics
VERA
Vera Therapeutics (VERA) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Leerink Partners | Initiated Coverage | Market Perform | $34.00 | Oct 12, 2026 |
| JP Morgan | Maintained | Overweight | $83.00 from $76.00 | Sep 8, 2026 |
| Wedbush | Maintained | Neutral | $34.00 | Aug 17, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $90.00 from $125.00 | Aug 12, 2026 |
| Wedbush | Maintained | Neutral | $34.00 from $43.00 | Aug 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $125.00 from $110.00 | Jul 8, 2026 |
| Guggenheim | Maintained | Buy | $76.00 from $56.00 | Jul 8, 2026 |
| TD Cowen | Maintained | Buy | $78.00 from $73.00 | Jul 8, 2026 |
| Wedbush | Maintained | Neutral | $43.00 from $35.00 | Jul 8, 2026 |
| B of A Securities | Maintained | Buy | $70.00 from $65.00 | Jul 7, 2026 |
| Evercore ISI Group | Maintained | Outperform | $91.00 from $95.00 | May 15, 2026 |
| Wolfe Research | Upgraded | Peer Perform → Outperform | $88.00 | Mar 11, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $110.00 from $90.00 | Mar 2, 2026 |
| JP Morgan | Maintained | Overweight | $96.00 from $99.00 | Dec 19, 2025 |
| Goldman Sachs | Maintained | Buy | $95.00 from $55.00 | Dec 19, 2025 |
| B of A Securities | Maintained | Buy | $66.00 from $48.00 | Dec 19, 2025 |
| Wedbush | Maintained | Neutral | $33.00 from $23.00 | Dec 11, 2025 |
| Evercore ISI Group | Maintained | Outperform | $97.00 from $75.00 | Dec 8, 2025 |
| TD Cowen | Maintained | Buy | $73.00 from $60.00 | Dec 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $90.00 from $85.00 | Nov 10, 2025 |
Frequently asked questions
What is the latest analyst rating on VERA?
On Oct 12, 2026, Leerink Partners initiated coverage of Vera Therapeutics at Market Perform with a price target of $34.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.